Hypophosphatemia in a patient with lymphoma in leukemic phase
- 1 May 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 141 (6) , 805-806
- https://doi.org/10.1001/archinte.141.6.805
Abstract
A patient with histiocytic lymphoma had abdominal masses, hypophosphatemia, normocalcemia and a normal serum parathyroid hormone value. After chemotherapy, transient hyperphosphatemia ensued, the abdominal masses resolved and other manifestations of the disease were suppressed. One week after discontinuation of the chemotherapy, the abdominal masses and other signs indicative of reactivation of the malignant disease reappeared. During the relapse, the serum phosphorus level fell to 0.7 mg/dl and urinary excretion of phosphorus became negligible. After resumption of chemotherapy, serum concentration and urinary excretion of phosphorus increased. Severe hypophosphatemia may be a complication of hematologic neoplasia. This abnormality may be caused by a shift of excessive amounts of extracellular phosphorus into the rapidly replicating malignant cells.This publication has 4 references indexed in Scilit:
- Treatment of Severe HypophosphatemiaAnnals of Internal Medicine, 1978
- 2,3-diphosphoglycerate, nucleotide phosophate, and organic and inorganic phosphate levels during the early phases of diabetic ketoacidosisDiabetes, 1977
- Hyperphosphatemia and hypocalcemia accompanying rapid cell lysis in a patient with Burkitt's lymphoma and Burkitt cell leukemiaThe American Journal of Medicine, 1977
- The pathophysiology and clinical characteristics of severe hypophosphatemiaArchives of internal medicine (1960), 1977